Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters

Country/Region as subject
Affiliation country
Publication year range
1.
Environ Res ; 252(Pt 2): 118653, 2024 Jul 01.
Article in English | MEDLINE | ID: mdl-38518907

ABSTRACT

BACKGROUND: In China, the effects of heavy metals and metalloids (HMMs) on liver health are not consistently documented, despite their prevalent environmental presence. OBJECTIVE: Our research assessed the association between HMMs and liver function biomarkers in a comprehensive sample of Chinese adults. METHODS: We analyzed data from 9445 participants in the China National Human Biomonitoring survey. Blood and urine were evaluated for HMM concentrations, and liver health was gauged using serum albumin (ALB), alanine aminotransferase (ALT), and aspartate aminotransferase (AST) metrics. Various statistical methods were employed to understand the relationship between 11 HMMs and liver function, adjusting for multiple factors. We also explored interactions with alcohol intake, gender, and age. RESULTS: Among HMMs, selenium in blood [weighted geometric mean (GM) = 95.56 µg/L] and molybdenum in urine (GM = 46.44 µg/L) showed the highest concentrations, while lead in blood (GM = 21.92 µg/L) and arsenic in urine (GM = 19.80 µg/L) had the highest levels among risk HMMs. Manganese and thallium consistently indicated potential risk factor to liver in both sample types, while selenium displayed potential liver protection. Blood HMM mixtures were negatively associated with ALB (ß = -0.614, 95% CI: -0.809, -0.418) and positively with AST (ß = 0.701, 95% CI: 0.290, 1.111). No significant associations were found in urine HMM mixtures. Manganese, tin, nickel, and selenium were notable in blood mixture associations, with selenium and cobalt being significant in urine. The relationship of certain HMMs varied based on alcohol consumption. CONCLUSION: This research highlights the complex relationship between HMM exposure and liver health in Chinese adults, particularly emphasizing metals like manganese, thallium, and selenium. The results suggest a need for public health attention to low dose HMM exposure and underscore the potential benefits of selenium for liver health. Further studies are essential to establish causality.


Subject(s)
Environmental Exposure , Environmental Pollutants , Liver , Metalloids , Metals, Heavy , Humans , China , Male , Female , Adult , Cross-Sectional Studies , Middle Aged , Metals, Heavy/urine , Metals, Heavy/blood , Metalloids/urine , Metalloids/blood , Metalloids/analysis , Liver/drug effects , Environmental Exposure/analysis , Environmental Pollutants/urine , Environmental Pollutants/blood , Young Adult , Aged , Liver Function Tests , East Asian People
2.
China CDC Wkly ; 4(52): 1185-1188, 2022 Dec 30.
Article in English | MEDLINE | ID: mdl-36779172

ABSTRACT

Introduction: To compare the performance between the compartment model and the autoregressive integrated moving average (ARIMA) model that were applied to the prediction of new infections during the coronavirus disease 2019 (COVID-19) epidemic. Methods: The compartment model and the ARIMA model were established based on the daily cases of new infection reported in China from December 2, 2019 to April 8, 2020. The goodness of fit of the two models was compared using the coefficient of determination (R2). Results: The compartment model predicts that the number of new cases without a cordon sanitaire, i.e., a restriction of mobility to prevent spread of disease, will increase exponentially over 10 days starting from January 23, 2020, while the ARIMA model shows a linear increase. The calculated R2 values of the two models without cordon sanitaire were 0.990 and 0.981. The prediction results of the ARIMA model after February 2, 2020 have a large deviation. The R2 values of complete transmission process fit of the epidemic for the 2 models were 0.964 and 0.933, respectively. Discussion: The two models fit well at different stages of the epidemic. The predictions of compartment model were more in line with highly contagious transmission characteristics of COVID-19. The accuracy of recent historical data had a large impact on the predictions of the ARIMA model as compared to those of the compartment model.

3.
China CDC Wkly ; 4(31): 685-692, 2022 Aug 05.
Article in English | MEDLINE | ID: mdl-36059792

ABSTRACT

Introduction: The aim of this study was to construct an assessment method for cross-regional transmission of coronavirus disease 2019 (COVID-19) and to provide recommendations for optimizing measures such as interregional population movements. Methods: Taking Xi'an City as the example subject of this study's analysis, a Cross-Regional-Gravitational-Dynamic model was constructed to simulate the epidemic in each district of Xi'an under three scenarios of controlled population movement (Scenario 1: no intensive intervention; Scenario 2: blocking Yanta District on December 18 and blocking the whole region on December 23; and Scenario 3: blocking the whole region on December 23). This study then evaluated the effects of such simulated population control measures. Results: The cumulative number of cases for the three scenarios was 8,901,425, 178, and 474, respectively, and the duration of the epidemic was 175, 18, and 22 days, respectively. The real world prevention and control measures in Xi'an reduced the cumulative number of cases for its outbreak by 99.98% in comparison to the simulated response in Scenario 1; in contrast, the simulated prevention and control strategies set in Scenarios 2 (91.26%) and 3 (76.73%) reduced cases even further than the real world measures used in Xi'an. Discussion: The constructed model can effectively simulate an outbreak across regions. Timely implementation of two-way containment and control measures in areas where spillover is likely to occur is key to stopping cross-regional transmission.

4.
China CDC Wkly ; 3(18): 394-395, 2021 Apr 30.
Article in English | MEDLINE | ID: mdl-34594891
5.
China CDC Wkly ; 3(19): 414-415, 2021 May 07.
Article in English | MEDLINE | ID: mdl-34594897
8.
China CDC Wkly ; 2(45): 887-888, 2020 Nov 06.
Article in English | MEDLINE | ID: mdl-34594787
9.
China CDC Wkly ; 2(38): 749-750, 2020 Sep 18.
Article in English | MEDLINE | ID: mdl-34594753
10.
China CDC Wkly ; 2(39): 767-768, 2020 Sep 25.
Article in English | MEDLINE | ID: mdl-34594758
11.
China CDC Wkly ; 2(40): 787-788, 2020 Oct 02.
Article in English | MEDLINE | ID: mdl-34594768
SELECTION OF CITATIONS
SEARCH DETAIL